Clinical Trials on Rapid-onset Dystonia-parkinsonism
Total 0 results
Nothing found
Sponsors and Collaborators
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Centro Universitário Franciscano
- the people hospital of Linzhi
- National Institute of Cardiovascular Diseases, Bangladesh
- Bassam Abdulkarim
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- ECMC
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Glasgow Western Infirmary
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Hospitales Universitarios Virgen del Rocío
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Sahachat Aueyingsak
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- AlpinARC
- Dr Philippe METELLUS
- Sublimity Therapeutics Holdco Limited
- Etan Orgel
- Daniela Pacella - University of Naples Federico II, Naples
- Åke Wibergs Stiftelse
- View Full List
Medical Conditions
- Degenerative Spondylolisthesis G1
- Value-Based Health Insurance
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Progression to PD-1 Antibody
- Hyperprolinemia
- Initiation of Depo-Provera (DMPA)
- Legal History
- Ability to Swim 100m Independent Freestyle
- Patients With Leptomeningeal Disease
- Eosinophil Blood Count
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Interviews
- Pancreaticoduodenectomy
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Orthopaedic Disorders
- Transitional Cell Carcinoma of Renal Pelvis
- Panniculectomy
- Genetic Risk Factor
- View Full List
Drug Interventions
- Paliperidone palmitate
- 6% hetastarch
- UFUR and Iressa
- Prasugrel
- HBM4003 and Triprilimab
- Mepivacaine
- 5-Fluoro-uracil
- Cefuroxime 750mg oral
- Nimotuzumab
- IV rtPA (intravenous recombinant plasminogen activator)
- Omeprazole 20mg
- Injectable Insulin
- Epirubicin hydrochloride
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Gefitinib
- 0% N2O
- ASP8062
- Antibiotic treatment
- Erythropoietin
- Metoclopramide + dexamethasone
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Colombia
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Guinea
- Contract Research Organizations in Ireland
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Qatar
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Singapore
- Contract Research Organizations in South Korea
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uzbekistan
- Contract Research Organizations in Venezuela
- CRO list by country